1. Home
  2. RMD vs TEF Comparison

RMD vs TEF Comparison

Compare RMD & TEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • TEF
  • Stock Information
  • Founded
  • RMD 1989
  • TEF 1924
  • Country
  • RMD United States
  • TEF Spain
  • Employees
  • RMD N/A
  • TEF N/A
  • Industry
  • RMD Medical/Dental Instruments
  • TEF Telecommunications Equipment
  • Sector
  • RMD Health Care
  • TEF Telecommunications
  • Exchange
  • RMD Nasdaq
  • TEF Nasdaq
  • Market Cap
  • RMD 31.8B
  • TEF 29.1B
  • IPO Year
  • RMD 1995
  • TEF 1987
  • Fundamental
  • Price
  • RMD $244.62
  • TEF $5.31
  • Analyst Decision
  • RMD Buy
  • TEF
  • Analyst Count
  • RMD 13
  • TEF 0
  • Target Price
  • RMD $259.40
  • TEF N/A
  • AVG Volume (30 Days)
  • RMD 916.1K
  • TEF 656.5K
  • Earning Date
  • RMD 04-23-2025
  • TEF 05-14-2025
  • Dividend Yield
  • RMD 0.87%
  • TEF 6.25%
  • EPS Growth
  • RMD 37.08
  • TEF N/A
  • EPS
  • RMD 8.91
  • TEF N/A
  • Revenue
  • RMD $5,021,529,000.00
  • TEF $44,356,895,792.00
  • Revenue This Year
  • RMD $10.37
  • TEF N/A
  • Revenue Next Year
  • RMD $7.77
  • TEF $0.17
  • P/E Ratio
  • RMD $27.47
  • TEF N/A
  • Revenue Growth
  • RMD 9.54
  • TEF 0.72
  • 52 Week Low
  • RMD $179.42
  • TEF $3.89
  • 52 Week High
  • RMD $263.05
  • TEF $5.31
  • Technical
  • Relative Strength Index (RSI)
  • RMD 56.30
  • TEF 67.86
  • Support Level
  • RMD $242.22
  • TEF $5.21
  • Resistance Level
  • RMD $247.48
  • TEF $5.25
  • Average True Range (ATR)
  • RMD 3.86
  • TEF 0.06
  • MACD
  • RMD -1.26
  • TEF 0.02
  • Stochastic Oscillator
  • RMD 21.98
  • TEF 100.00

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About TEF Telefonica SA

Telefonica operates mobile and fixed networks in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.

Share on Social Networks: